Dr Saul Johnson joins the Good Things Guy to chat about COVID-19 vaccines in South Africa.
Johannesburg, South Africa (15 June 2021) – It’s been almost 450 days since the pandemic really took hold of South Africa… yup, that’s how long it has been since the country went into the initial lockdown. Crazy just saying that out loud.
But we have made massive strides and are now in the second phase of the vaccine program in South Africa.
“For me, vaccinations are the next step in getting back to some sort of normal, but for a few, they are still quite sceptical, so… I’ve invited Dr Saul Johnson to join us in a discussion about vaccines!” – Brent Lindeque
Dr Johnson has a medical degree from the Wits and a Master’s degree in Epidemiology from Columbia University in New York. He lectures extensively on epidemiology and research methodology and has worked as a doctor, epidemiologist, researcher and project manager in various African countries.
Listen to the full interview here:
The Solidarity Fund joins government and the medical fraternity for the second phase of the vaccination drive which kicked off on the 17th May 2021, to encourage those who are 60 years and older, to register to be vaccinated.
The Solidarity Fund was designed as a rapid response vehicle to mobilise South Africa against the COVID-19 pandemic and the resulting health, humanitarian and social consequences. The incredible initiative is a nonprofit organization that is set up to support Mzansi with the South African spirit of ubuntu in these unprecedented times.
“This has always been the South African way. Now more than ever, we need to remember that we are a nation of people who overcome, who encourage and uplift each other and who can inspire new ways of being. We will overcome COVID-19 together and will be stronger as a nation,” says Wendy Tlou, The Solidarity Fund’s head of the Humanitarian Response and Behaviour Change Pillars.
For more information on the benefits and facts about the COVID-19 vaccine, please check out the Solidarity Fund by clicking here.